In the US, Rimantadine (rimantadine systemic) is a member of the drug class adamantane antivirals and is used to treat Influenza A and Influenza Prophylaxis.
US matches:
- Rimantadine
- Rimantadine Syrup
- Rimantadine Hydrochloride
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
J05AC02
CAS registry number (Chemical Abstracts Service)
0013392-28-4
Chemical Formula
C12-H21-N
Molecular Weight
179
Therapeutic Category
Antiviral agent
Chemical Name
Tricyclo[3.3.1.13,7]decane-1-methanamine, α-methyl-
Foreign Names
- Rimantadinum (Latin)
- Rimantadin (German)
- Rimantadine (French)
- Rimantadina (Spanish)
Generic Names
- Rimantadine (OS: BAN, DCF)
- Rimantadine Hydrochloride (OS: USAN, BANM)
- EXP 126 (IS: DuPont Merck)
- Rimantadine hydrochloride (PH: USP 32)
Brand Names
- Remantadins
Olainfarm, Lithuania - Flumadine
Caraco, United States - Gabirol
Chinoin, Costa Rica; Chinoin, Dominican Republic; Chinoin, Mexico; Chinoin, Nicaragua; Chinoin, El Salvador - Remantadin
Olainfarm, Bulgaria - Remantadins
Olainfarm, Latvia - Rimantadine Hydrochloride
Actavis, United States; CorePharma, United States; Global, United States; Impax, United States
International Drug Name Search
Glossary
BAN | British Approved Name |
BANM | British Approved Name (Modified) |
DCF | Dénomination Commune Française |
IS | Inofficial Synonym |
OS | Official Synonym |
PH | Pharmacopoeia Name |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
USAN | United States Adopted Name |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment